SCHEMBL21828347

SCHEMBL21828347

CCCCCCCCCCC(=O)OCCCCCCBr

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.74
NAAA Q02083 1/20 0.62
PRSS1 P07477 1/20 0.61
PRSS2 P07478 1/20 0.61
PRSS3 P35030 1/20 0.61
FAAH O00519 2/20 0.61
DNM1 Q05193 1/20 0.61
HTR2C P28335 1/20 0.59
PAM P19021 2/20 0.56
TSHR P16473 1/20 0.53
MAPT P10636 1/20 0.53
RAD52 P43351 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
EPHX2 P34913 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25355680 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL25191417 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL24573011 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL25120998 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL25121055 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL25181489 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL23605993 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL25259134 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL25342186 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3
SCHEMBL24588753 1.00 DGKA (0.74) DGKANAAAPRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113039174-B Ionizable amine lipids 英特利亚治疗股份有限公司 2023-11-17 CN disclosed
US-20220009878-A1 IONIZABLE AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2022-01-13 US disclosed
US-20220009878-A1 IONIZABLE AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2022-01-13 US disclosed
EP-3860972-A1 IONIZABLE AMINE LIPIDS Intellia Therapeutics, Inc. (US) 2021-08-11 EP disclosed
CN-113039174-A Ionizable amine lipids 英特利亚治疗股份有限公司 2021-06-25 CN disclosed
WO-2020072605-A1 IONIZABLE AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-04-09 WO disclosed
WO-2020072605-A1 IONIZABLE AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009878-A1 IONIZABLE AMINE LIPIDS PHOSPHO1, SGMS1, SGMS2 DGKA 312/4885NAAA 36/4885PRSS1 3614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.